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The site of deposition of pulmonary delivered aerosols is dependent on the aerosol's
droplet size distribution, which may change during inhalation. The aim of this study was
to develop a freely accessible and adaptable model that describes the growth (due to
condensation) and shrinkage (due to evaporation) of inhaled droplets as a function of the
distance from the airway wall during various inhalation conditions, for a laminar ﬂow
scenario. This was achieved by developing a model with which the evaporation of water
from a droplet surface or condensation of water onto the droplet surface can be calculated.
This model was then applied to a second model that describes the heat and mass transfer
from the airway wall to the inhaled aerosol. The latter was based on the Weibel model. It
was found that the growth and shrinkage of inhaled droplets markedly differs, depending
on the distance from the airway wall. Droplets near the wall start to grow immediately
due to fast water vapor transfer from the wall to the cold inhaled air. This growth con-
tinues until the air reaches body temperature and is fully saturated. However, droplets in
the center of the airway ﬁrst evaporate partly, due to a delay in water vapor transfer from
the airway wall, before they start to grow. Depending on the conditions during inhalation,
the droplet size distribution can widen considerably, which may affect the lung deposition
and thereby the efﬁcacy of the inhalation therapy. In conclusion, the model was able to
show the effect of the conditions in the respiratory tract on the growth and shrinkage of
inhaled droplets during standard inhalation conditions. Future developments can be
aimed at expanding the model to include turbulent ﬂow and hygroscopic growth, to
improve the accuracy of the model and make it applicable to both droplets of solutions
and dry particles.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Inhalation of drugs is widely applied in the treatment of asthma and COPD. Furthermore, the pulmonary route is cur-
rently targeted for the treatment of diseases that are not directly located or even associated with the respiratory tract. Due
to the proximity of the capillaries and blood vessels with the lining in the respiratory tract and the leaky nature of the
pulmonary membranes (especially in the alveoli), the absorption of active pharmaceutical ingredients can be extremely
rapid (Patton, 1996; Rabinowitz et al., 2006). However, the rate and amount of absorption heavily depend on the location ofer Ltd. This is an open access article under the CC BY license
x: þ31 50 363 2500.
ichs).
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1994).
During a standard inhalation procedure, the largest particles (either dry powder or droplets, although in this paper only
aqueous droplets will be considered) are deposited in the mouth and the back of the throat, meaning their effect is
essentially lost. The rest of the particles are deposited throughout the respiratory tract, where the spread of deposition is
mainly dependent on the particle size distribution of the liquid aerosol or dry powder. This aerosol’s particle size dis-
tribution is ideally tailored to obtain deposition at a location where it is desired for a speciﬁc application. As a general rule of
thumb, particles with an aerodynamic diameter larger than 5 mm are deposited in the throat and smaller than 1 mm are
exhaled after inhalation (Labiris & Dolovich, 2003). Anything in between is deposited in the lung, with smaller particles
having a higher chance to reach the peripheral parts of the lung and even the alveoli and larger particles being deposited
more centrally in the respiratory tract. However, in reality it is more complex.
When particles are inhaled, they are subjected to quickly changing conditions. When the particles exit the inhaler
together with the ambient air, conditions surrounding the particles closely match those of the ambient air, which means
relatively low relative humidity and room temperature. During the passage through the respiratory tract, the relative
humidity quickly increases as well as the temperature. For both dry powder and liquid aerosols, this could affect their
aerodynamic diameter, as the increased humidity could cause the dry powder particles to get wet and grow, while droplets
in the liquid aerosol could grow due to condensation or shrink due to evaporation. If it would be possible to tell whether,
and if so, howmuch the aerodynamic diameter of inhaled particles is changed while traversing the respiratory tract, it could
aid in optimizing formulations for inhalation. By taking into account growth and/or shrinkage of the particles, the
deposition location in the respiratory tract could be further tailored for each treatment.
Indeed, a lot of effort has gone into modeling the condensational growth of solid submicron particles during inhalation to
allow targeted deposition in the respiratory tract, mainly by Longest et al. (Ferron, 1977; Golshahi et al., 2013; Hindle &
Longest, 2010; Longest & Hindle, 2010, 2011, 2012; Longest, McLeskey & Hindle, 2010; Longest, Tian & Hindle, 2011; Longest,
Tian, Li, Son & Hindle, 2012; Tian, Longest, Li & Hindle, 2013; Tian, Longest, Su & Hindle, 2011; Worth Longest et al., 2012)
but others as well (Broday & Georgopoulos, 2001; Kleinstreuer & Zhang, 2010). In addition, a lot is known about the con-
ditions to which inhaled particles and droplets are subjected when inhaled (Ferron, 1977; Olson, Sudlow, Horsﬁeld & Filley,
1973; Tian, Longest, Su & Hindle, 2011). Most of these studies revolve around the use of computational ﬂuid dynamics (CFD),
which is an excellent method to accurately model the complex ﬂow proﬁles that exist inside the airways. However, such
models lack openness and accessibility for researchers who are not directly involved in such ﬁelds. The same can be said for
more analytical models that use pre-formulated sets of equations that describe, for example, the evaporation rate from a
droplet. Furthermore, the complete models are not readily available online. Although simpler models using standard heat
and mass balances usually result in less detailed results, their use often allows more openly accessible models to be
developed that can be used and adapted by others. In addition, given enough effort, the complexity of the model can be
increased to obtain more accurate results. Furthermore, we believe that understanding the basic mechanics underlying such
a model can also greatly increase the understanding of the system under consideration.
Therefore, the aim of this study is to investigate the behavior, i.e. growth and shrinkage, of inhaled particles in the
respiratory tract with a theoretical model based on standard heat and mass balances. This will be done by primarily focusing
on aqueous particles. Although dissolved components such as drugs and excipients will be left out of the model to prevent it
from becoming overly complex, the model will be constructed such that it can be expanded by anyone who wishes to do so.
Therefore, the model will be developed in an open source platform called GNU Octave and be made available freely.
Consequently, a model will be obtained that can form a basis for further expansion and development to create a more
complex but also more complete model of dry particle and droplet behavior in the respiratory tract without resolving to
CFD. Finally, the clinical relevance of the results of this study towards inhalation practices will also be discussed.2. Materials and methods
2.1. Open source software
The model was developed entirely in GNU Octave, which is freely available (Eaton & Community, 2014). Furthermore, the
developed model itself is available online as Supplementary data.
2.2. Model input parameters
The basis for the input of the models was obtained from the Respimat
s
soft mist inhaler (Boehringer Ingelheim,
Ingelheim, Germany). The inhaled jet that is ejected from the inhaler contains about 15 mg of water and lasts for about 1.2 s.
Furthermore, the starting droplet diameter is 4.5 mm (Dalby, Eicher & Zierenberg, 2011). For the simulations, an inhalation
ﬂow of 40 L/min was chosen, although for comparison, a fast inhalation with an inhalation ﬂow of 100 L/min will also be
considered (Brand, Hederer, Austen, Dewberry & Meyer, 2008). Finally, a room temperature of either 293 K or 303 K, and a
relative humidity of either 35, 50 or 70% will be used. Note that all of these parameters can be easily customized in the
developed model, if desired.
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that each droplet will be of equal size and separated by an equal distance from each other and therefore, the volume of air
surrounding each droplet will be the same. To simplify the model, the layer of air around each droplet is considered to be a
spherical shell instead of cubical. The volume of air around each droplet is then simply calculated by dividing the amount of
air inhaled during the ejection of the jet from the inhaler by the amount of droplets generated. Furthermore, the droplet is
assumed to move at the same velocity as the surrounding air, which implies that the air surrounding each droplet can be
considered as stagnant.
2.3. Modeling strategy
The complete model for predicting the behavior of droplets in the respiratory tract consists of two separate models that
work together. The ﬁrst (droplet) model describes the mass transfer of water and energy from and to a water droplet, which
will be described in the ﬁrst section. The second (respiratory tract) model will describe the conditions inside the respiratory
tract, and will also be based on mass and energy balances. With the respiratory tract model, the exchange of heat and mass
between the airway wall and the inhaled air is ﬁrst calculated. The changes in relative humidity and temperature are then
passed on to the droplet model to calculate the exchange of heat and mass between the droplet and the inhaled air. By
keeping the models separated, it is very easy to vary the amount of droplets that are considered during the calculation. The
development of the respiratory tract model will be described in further detail in the second section.
2.4. Droplet model
The droplet model was developed as a 1-D model, meaning that the system is completely symmetrical and changes in
morphology are not considered.
The primary aim of the droplet model is to calculate the changes in droplet radius as a function of the conditions to
which the droplet is exposed inside the respiratory tract. To achieve this, the basic equation shown in Eq. (1) was used to
start the calculation.
rt ¼ mt1ϕm∙Δt
ρ
∙
3
4∙π
 1
3
ð1Þ
where rt is the radius of the droplet at time t, mt1 is the mass of liquid at the previous time point, Φm is the mass ﬂow rate
from the droplet to the environment (or vice versa when negative), Δt is the time step for the iterative calculation, and ρ is
the density of the liquid (1000 kg/m3 for water, assumed to be constant). Because the mass ﬂow rate (Φm) is still unknown,
Eq. (2) (derived from Fick's ﬁrst law) has to be used to calculate the rate of mass ﬂow from or towards the droplet.
ϕm ¼ D ∙
4∙π∙Mw∙Δp
R∙T∙ 1rd
1
ra
  ð2Þ
where D is the diffusion coefﬁcient of water molecules in the gas phase, Mw is the molecular mass of the liquid, Δp is the
pressure difference between the partial water vapor pressure at the surface of the droplet and the partial water vapor
pressure in the gas phase, R is the gas constant, T is the temperature at the surface of the droplet (K), rd is the radius of the
droplet and ra is the total radius of the droplet and gas phase surrounding the droplet. Here, it is assumed that the partial
water vapor pressure at the surface of the droplet is equal to the saturation pressure. Therefore, the pressure gradient, Δp,
can be calculated with both the Antoine equation and the ideal gas law (Eqs. (3) and (4), respectively).
psat ¼ 10A
B
C þ T ð3Þ
pvap ¼
x∙ρg∙R∙T
Mw
ð4Þ
where psat is the saturated vapor pressure (Pa), A, B and C are the Antoine constants (for water these are 10.20, 1730.63, and
39.72, respectively (Yaws & Yang, 1989)), T is the temperature (K), pvap is the partial water vapor pressure (Pa), x is the
speciﬁc humidity (deﬁned as the mass of water divided by the mass of dry air) and ρg is the density of the gas phase. Besides
the partial water vapor pressure gradient, the above equations can also be used to calculate the relative humidity (RH),
which is deﬁned as pvap/psat  100.
The temperature in the equations for the mass ﬂow rate (Eq. (2)) and both the vapor pressures (Eqs. (3) and (4)) can be
calculated with Eq. (5).
Tt ¼ Tt1þ
Q∙Δt
Cp∙m
ð5Þ
where Tt1 is the temperature at the previous time point, Q is the heat ﬂow rate, Cp is the speciﬁc heat capacity of the
considered phase and m is the mass. The heat ﬂow rate consists of heat ﬂow through conduction and evaporation, which
can be calculated using Eq. (6) (derived from Fourier's law) and Eq. (7), respectively. Note that Eqs. (2) and (6) are similar due
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Qcond ¼ λ ∙
4∙π∙ΔT
1
rd
 1ra
  ð6Þ
Qevap ¼Hevap∙ϕm ð7Þ
where λ is the thermal conductivity (W/m/K), ΔT is the temperature difference between the temperature at the surface of
the droplet and the temperature at the boundary of the gas layer surrounding the droplet and Hevap is the heat of eva-
poration of the liquid. Note that the heat of evaporation is equal to the negative of the heat of condensation. Whether or not
the heat is added to (condensation) or subtracted from (evaporation) the heat of the droplet purely depends on whether
mass is ﬂowing towards or from the droplet, respectively. By iterating Eqs. (1)–(7), the radius of the droplet in time can be
calculated as a function of the conditions to which the droplet is subjected.
2.5. Respiratory tract model
To simulate the conditions inside the respiratory tract to which the droplet is subjected, a second model was developed.
Whereas the droplet model is used to calculate the exchange of heat and water between a droplet and the surrounding gas
phase, the respiratory tract model calculates the exchange of heat and water between the airway wall and the inhaled mist.
Furthermore, because the dimensions of the airways that a droplet is passing through changes with each generation
(sections of the airway between bifurcations, with the trachea being generation zero), these are taken into account as well.
These dimensions are given by the Weibel lung model, and are shown together with the cumulative residence time of the
droplets in Table 1 (Weibel, 1963).
In this respiratory tract model, the heat and mass transfer that occurs during passage from the inhaler through the
mouth to the beginning of the trachea is not considered. This is done to simplify the model, since the dimensions of the
mouth during inhalation are not well deﬁned. The aerosol that is inhaled will be at ambient conditions, meaning room
temperature and RH, and will start to heat up the moment it reaches the trachea. During the travel through the airways heat
and mass is transferred from the airway wall to the center of the airway, increasing both the temperature and the RH of the
air surrounding the droplets. This can then lead to evaporation or condensation from or onto the droplets, until equilibrium
is reached or droplets are evaporated. In reality, heat and water will also be transferred to the inhaled air during travel to the
trachea, which will affect the generation where the equilibrium is reached (Hindle & Longest, 2010; Olson, Sudlow,
Horsﬁeld & Filley, 1973; Tian, Longest, Su & Hindle, 2011).
For this respiratory tract model, the airway is considered to be a smooth cylinder consisting of concentric cylinders to
divide the area inside the airway (see Fig. 1). The content of each of the cylinders are considered to be ideally mixed,
meaning that there is no variation in conditions within each cylinder at any time point. This will result in a stepwiseTable 1
Respiratory tract dimensions according to the Weibel lung model (Weibel, 1963).
Generation Diameter (mm) Length (mm) Number Cumulative residence time (ms)a
0 18.0 120.0 1 45.8
1 12.2 48.0 2 62.6
2 8.3 19.0 4 68.8
3 5.6 8.0 8 71.2
4 4.5 13.0 16 76.1
5 3.5 10.7 32 81.1
6 3.2 9.9 64 88.9
7 3.0 9.1 128 101.0
8 2.7 8.2 256 119.2
9 2.4 7.4 512 146.0
10 2.2 6.6 1024 184.0
11 1.9 5.8 2048 235.4
12 1.7 5.0 4096 301.1
13 1.4 4.2 8192 378.6
14 1.1 3.3 16,384 460.5
15 0.9 2.5 32,768 533.0
16 0.6 1.7 65,536 580.2
17 0.6 1.5 131,072 652.9
18 0.5 1.2 262,144 761.3
19 0.5 1.0 524,288 915.7
20 0.5 0.9 1,048,576 1159.6
21 0.5 0.8 2,097,152 1534.8
22 0.4 0.6 4,194,304 2092.6
23 0.4 0.5 8,388,608 2883.2
a Cumulative residence time for an inhalation ﬂow rate of 40 L/min.
Fig. 1. Schematic overview of the modeled airway with a top view on the left and a side view on the right. Left: Each concentric cylinder transfers mass and
heat but there is no variation in conditions inside each cylinder. The arrows depict the transfer of mass and heat from the airway wall through each cylinder
to the center of the airway. Right: The airway is considered to be a straight smooth cylinder without bifurcations but with sudden changes in diameter,
through which a slice of the inhaled mist is followed.
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number of chosen concentric cylinders. Furthermore, at each bifurcation (when a new generation is reached) the dimen-
sions are changed such that the same number of cylinders will be kept the same, together with the conditions in each ring at
that time point. Although in reality the ﬂow might be split through the middle at each bifurcation leaving half the inner
cylinder on the outside, in this model the distribution of the concentric cylinders inside the airway does not change when a
bifurcation is passed. How this might affect the result will be discussed. In addition, loss of droplets due to impaction is not
taken into account. Finally, the mass and heat transfer is modeled for a laminar ﬂow, thereby neglecting the slightly tur-
bulent ﬂow in the ﬁrst two to four stages and the effect of droplets on the ﬂow (one-way coupling). Although this will
impose an error on the ﬁnal estimated behavior of droplets inside the respiratory tract, the importance and magnitude of
this error will also be discussed.
The calculations for the respiratory tract model are comparable to the calculations that are done in the droplet model.
The mass transfer between the concentric cylinders is calculated using Eq. (8) and the heat conduction is calculated using
Eq. (9), derived from Fick's law and Fourier’s law, respectively.
ϕm ¼ D ∙
4∙π∙h∙Mw∙Δp
R∙T∙ln rnþ 1rn
  ð8Þ
Qcond ¼ λ∙
2∙π∙h∙ΔT
ln rnþ 1rn
  ð9Þ
where h is the height of the considered layer of mist moving through the respiratory tract (arbitrarily chosen as the diameter
of the droplet with its surrounding gas layer), rn and rnþ1 are the radii of two adjacent concentric cylinders n and nþ1 in the
airway, respectively, and Δp and ΔT are the partial water vapor pressure and temperature of cylinder n and nþ1,
respectively.
Finally, the evaporation of water from the airway wall to the airway is assumed to occur through a small 1 mm boundary
layer with 99.5% RH at body temperature (Ferron, 1977), and for the heat transfer to the airway, the thickness of the airway
wall decreases from 2.75 mm in the trachea to about 1 mm at generation 11, after which it is assumed to remain constant
(Liu, Chen, Tawhai, Hoffman & Sonka, 2009). The thermal conductivity, λ, used for the airway wall is about 0.28 W/m/K
(Poppendiek et al., 1964). It is important to realize that the outer cylinder, due to the ideally mixed conditions, will not be at
the body temperature from the start.
2.6. Combined model
The droplet model and the respiratory tract model are combined to calculate the growth and shrinkage of a droplet in
each concentric cylinder in the respiratory tract model. For each droplet, the heat and water transfer from or onto the
droplet is calculated. In addition, the heat and water transfer between each concentric cylinder in the airway is also
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relative humidity in each concentric cylinder and droplet is obtained after each time step. Furthermore, after the simulated
time in each generation surpasses the residence time of that speciﬁc generation (Table 1), the dimensions of the concentric
cylinders are instantly changed to that of the next generation. To keep calculation times limited, while still obtaining a good
resolution of the size distribution of droplets inside the airway, the airway was divided into 30 cylinders and thus 30
droplets were modeled between the airway wall and the center of the airway.3. Results
3.1. Droplet model
A model was developed that describes the heat and mass transfer to and from a liquid droplet. To validate the accuracy of
the droplet model alone (without external inﬂuences, e.g. as imposed by the respiratory tract model), the output as shown
in Table 2 was compared to data found in a psychrometric chart. This chart gives information on the temperature of a
droplet dispersed in air with a speciﬁc temperature and humidity. When a droplet is exposed to air with a moisture content
below the dew point, the droplet will evaporate. Due to the evaporation, the temperature of the droplet will decrease to a
speciﬁc temperature, the wet bulb temperature, which is dependent on the rate of evaporation. This effect is referred to as
evaporative cooling. The rate of evaporation, and consequently the equilibrium temperature of the droplet, is dependent on
the relative humidity, the ambient temperature, the type of liquid (in this case only water is considered), and the velocity
difference between the ambient air and the droplet. For this case it was assumed that the velocity of the droplet is equal to
the velocity of the surrounding air, i.e. there is a stagnant layer of air surrounding the droplet. Furthermore, the droplet
diameter at the start of the simulation was 4.5 mm. Finally, the droplet temperature (Tw model) was calculated at three
different relative humidities, i.e. 0%, 50% and 95%, at an ambient temperature of 293 K and compared to values found in a
psychrometric chart at similar conditions (Tw chart). It was found that the calculated droplet temperatures were in full
agreement with values found in psychrometric charts. Therefore, it can be concluded that the mass and heat transfer in the
droplet model is modeled correctly and accurately. Since the same calculations were used for the mass and heat transferTable 2
Comparison of calculated droplet temperature in stagnant air at 0%, 50% and 95% RH with the wet bulb temperature found in psychrometric charts.
RH (%) Tw model (K)a Tw chart (K)
0 278.7 279
50 286.8 287
95 292.6 293
a The wet bulb temperature was reached within 1 ms, after which the droplet temperature remained constant
Fig. 2. Condensational growth of droplets suspended in air at 37 °C and a relative humidity of 99.5% (- and o), 100% (–and Δ), 101% (-  -and □), or 104%
(    and ◇). Lines depict values calculated with the droplet model, whereas symbols represent values reported by Longest, McLeskey & Hindle, (2010).
Values reported by Longest et al. include hygroscopic effects. Original droplet diameter at start of simulation was 0.9 mm.
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for this model (i.e. laminar ﬂow).
To further show the application of the droplet model to the growth of droplets due to condensation, a simulation was run
for droplets with a diameter of 0.9 mm suspended in air of 37 °C with a relative humidity of 99.5, 100, 101 or 104%. The
volume of air surrounding the droplets was high enough to negate any effect of evaporation and condensation of the
droplets on the relative humidity. These settings were speciﬁcally chosen to be able to compare the results to data reported
by Longest, McLeskey & Hindle (2010), to determine whether the rate of condensation is correctly modeled (see Fig. 2).
Although the values reported by Longest et al. include the effect of hygroscopic growth (starting droplets consisted of a 0.5%
w/v albuterol sulfate solution), at higher relative humidity it is expected that growth due to condensation will be high,
causing a high dilution of the solution and in turn reducing the effect of hygroscopic growth. At a relative humidity of 104%
the growth rate corresponds well with the values reported by Longest et al. for condensational growth of droplets con-
taining albuterol sulfate. When the relative humidity is 101%, the effect of hygroscopic growth is noticeable as the con-
densational growth rate calculated with our droplet model is slightly lower. However, at a relative humidity of 100% and
99.5% the difference is much more pronounced: droplets without solutes evaporate, whereas values reported by Longest
et al. still show growth due to hygroscopic effects.Fig. 3. Relative humidity (black) and temperature (gray) in the airway during inhalation. The results are shown for a simulation with 30 concentric
cylinders with 30 modeled droplets. Locations closest to the airway wall are shown at the top and locations closer to the center of the airway are shown at
the bottom. Inhaled air was assumed to have 35% RH and 293 K. Inhalation ﬂow rate was 40 L/min.
Fig. 4. Change in droplet size (black) while traveling through the airways depending on the distance from the airway wall. The stepwise line (gray) depicts
changes in generation of the airway. Droplets closest to the airway wall are shown at the top, while droplets in the center are shown at the bottom. Original
droplet diameter at start of simulation was 4.5 mm, inhaled air with 35% RH, 293 K, 40 L/min.
Fig. 5. Droplet size distribution of modeled droplets at the end of generation 10. The original droplet diameter at the start of the simulation was 4.5 mm,
inhaled air with 35% RH, 293 K, inhaled at 40 L/min.
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The airway was divided into 30 concentric cylinders and for each cylinder the behavior of a droplet was modeled. For the
default simulation, the ambient air temperature and relative humidity used were 293 K and 35%, respectively. In addition,
the starting diameter for each droplet was 4.5 mm. For each of the droplets the surrounding air temperature and relative
humidity are shown in time (Fig. 3). Furthermore, the diameter of each of the droplets in time is shown in relation to the
generation where the droplets are located during the simulation (Fig. 4). Finally, the droplet size distribution was calculated
when the system reached equilibrium and the droplet diameter did not change any further (Fig. 5).
The relative humidity and the temperature close to the wall of the airway increased very rapidly. However, due to the
assumption that the ﬂow is laminar, the temperature in the center of the airway does not increase immediately. Only after
about 0.075 s (less for locations closer to the airway wall) the temperature in the center of the airway increased to body
temperature. Therefore, depending on the location inside the airway, inhaled droplets are subjected to different conditions.
A noticeably high relative humidity was found during the initial entry of the colder inhaled air into the trachea of about
240% closest to the wall, implying supersaturation. This quickly decreases again as the temperature increases and the water
vapor diffuses to the center of the airway. During the stage where the temperature of the airway has not yet reached body
temperature, the simulated relative humidity never decreased below 110%. In fact, a slight increase to about 125% is seen at
the same time when the temperature of the air further from the airway wall starts to increase rapidly. This is due to a quick
decrease in the diameter of the airway, by which the diffusion rate of water vapor and heat rapidly increases. Another effect
that results from a change in the diameter of the airway (and thus the modeled concentric cylinders) is the slight drop in
temperature that can be observed at several time points. Here, the heat diffusion towards the center is suddenly increased,
decreasing the temperature near the airway wall until a new equilibrium is reached and the temperature increases again.
The effect of the supersaturation, i.e. relative humidities higher than 100%, on the behavior of the droplets will be inves-
tigated further below in the results section entitled: “Droplet behavior – Maximum relative humidity”, as nucleation and
formation of separate water droplets which might occur by this supersaturation will affect the results shown in Figs. 3–5.
A clear inﬂuence of the location of the droplet in the airway on the droplet behavior was found. Droplets closest to the
airway wall grew, while the droplets in the center of the airway ﬁrst shrunk and after a while started to grow. This is clearly
the result of the higher relative humidity and temperature near the airway wall and the lower relative humidity and
temperature at the center of the airway. Air near the airway wall is quickly humidiﬁed and heated by the airway wall, which
causes condensation on the cooler droplets. On the other hand, moisture and heat from the airway wall takes a while to
reach the air in the center of the airway (farthest from the airway wall). Therefore, droplets near the center of the airway
will ﬁrst evaporate until the air is saturated, which is when the droplet size reaches a plateau value. Due to evaporative
cooling, the temperature of the air will also decrease. When the heat and moisture from the airway wall reaches these air
layers, the relative humidity and temperature increases rapidly, resulting in condensation on the droplets. Finally, no large
changes in droplet size occur after generation 9–10 because equilibrium was reached, although there is a slight and steady
evaporation of the droplets due to the lower relative humidity of the airway wall (99.5%).
When the actual droplet size distribution after reaching equilibrium is considered (Fig. 5), a large widening of the droplet
size distribution is found, ending up with a major volume fraction of the droplets larger than the originally inhaled droplets.
Under the simulated circumstances (inhaled air with 35% RH, 293 K, 40 L/min) about 63% of the total droplet volume had a
diameter above 4.5 mm, which was the original size of the inhaled droplets.
Fig. 6. Comparison of equilibrium droplet size distribution with relative humidity in the airway being: limited to 100% (), limited to 104% ( ) and
unlimited (  ) relative humidity. The original droplet diameter at the start of the simulation was 4.5 mm, inhaled air with 35% RH, 293 K, inhaled at
40 L/min.
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In the previous simulation, the maximum relative humidity in the airway was not limited. In reality, however, the
relative humidity might be limited by nucleation and formation of separate water droplets (mist). Although in the current
model, the formation of these droplets is not considered, the maximum relative humidity can easily be changed. Because the
relative humidity has a large inﬂuence on the condensation and evaporation rate (and thus droplet growth and shrinking), a
simulation was run to compare three relative humidity settings: unlimited (same as in Figs. 3–5), limited to 104% and
limited to 100% (Fig. 6). The relative humidity of 104% was added to match that used by Longest et al. (Longest & Hindle,
2010; Longest, McLeskey & Hindle, 2010), in addition, it was added to serve as a scenario for modest supersaturation, i.e.
between no supersaturation (100% RH) and unlimited supersaturation.
When the maximum relative humidity is limited to a maximum of 100% or 104%, a clear overall decrease of the droplet
size was found when compared to droplets at unlimited maximum relative humidity. However, it is questionable whether
limiting the maximum relative humidity would result in a better representation of conditions during inhalation. It is well
known that the degree of supersaturation required for nucleation depends strongly on purity of the liquid and the air. Under
ideal circumstances (no impurities), the relative humidity corresponding to the supersaturation required for homogeneous
nucleation can be as high as 2200% (Hinds, 1999). The presence of any nuclei, either droplets or other particles, will lower
the relative humidity at which condensation occurs. Therefore, in our situation, a lot of the water might actually condensate
on the inhaled droplets instead of forming new droplets. In addition, by limiting the relative humidity in the model, a lot of
the water that will evaporate from the airway wall to the cooler and drier inhaled air is simply ignored. In other words, all
the extra water that evaporates from the airway wall nucleates and does not interact with the droplets in any way. Most
likely, in reality some or perhaps most of the moisture may condense onto or agglomerate with the droplets. Finally, the
time during which the relative humidity reaches values well above 100% is quite short. The initial burst in relative humidity
before being dissipated by transport and condensation is less than 0.02 s (Fig. 3), and the total time before equilibrium is
reached with the airway wall is about 0.12 s. Although it is unknown what time scales are involved with the formation of
nuclei, it might be possible that the high relative humidities observed in Fig. 3 can be reached for such short duration, even
when impurities are present in the inhaled air (besides the droplets themselves). Therefore, it is expected that the results
with the unlimited model are more accurate than the model with limitations with respect to RH. However, below both
unlimited and limited relative humidity will be considered to better assess the importance of different conditions during
inhalation on the behavior of inhaled droplets in the respiratory tract.
3.4. Droplet behavior – inlet conditions
Because the conditions at which an inhaler is used can vary signiﬁcantly, the equilibrium droplet size distribution of
droplets inhaled under varying conditions was calculated (Fig. 7). The conditions chosen were an inhaled air temperature of
293 K with a relative humidity of 35%, 50%, and 70%. Furthermore, the inﬂuence of inhaled air temperature was determined
with an air temperature of 303 K and a relative humidity of 35%. These conditions were simulated with a relative humidity
that was either not limited, limited to a maximum of 104%, or limited to a maximum or 100%. Finally, all conditions were
simulated during a slow inhalation (40 L/min) and a fast inhalation (100 L/min).
Fig. 7. Comparison of equilibrium droplet size distribution after slow inhalation of air (40 L/min, left) or fast inhalation of air (100 L/min, right), with a
relative humidity that was not limited (top), limited to a maximum of 104% (middle), or limited to a maximum of 100% (bottom). Simulated inhalation
conditions were a relative humidity of 35% (), 50% ( ) and 70% (  ) at 293 K and 35% at 303 K (    ). The original droplet diameter at the start of
the simulation was 4.5 mm.
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noticeable effect on the smallest droplet size. When air with a higher relative humidity was chosen, the diameter of the
smallest droplets increased. This is caused by a faster saturation of the air closer to the center of the airway when it is not yet
heated by the airway wall. Therefore, the droplets evaporate less and the minimum droplet diameter increases.
When the inhaled air temperature was 303 K instead of 293 K, a large overall decrease of the droplet diameter was
observed. For droplets closest to the airway wall the higher inhaled air temperature resulted in a lower super saturation of
the air with moisture (data not shown). Therefore, the condensation rate onto the droplets was lower than onto droplets in
air with a lower temperature. This effect was absent when the relative humidity in the airway was limited to a maximum of
104% and 100%, and the maximum droplet size does not change with a change in inhaled air temperature. Droplets closer to
the center of the airway became smaller with increased inhaled air temperature, due to the higher moisture capacity. Air
with a ﬁxed relative humidity but a higher temperature will have a higher absolute moisture content before becoming
saturated. Therefore, droplets can evaporate more before the air is saturated and equilibrium is reached.
When the inhalation is performed quickly, i.e. at 100 L/min instead of 40 L/min, an overall decrease in droplet size was
found. In addition, the effects of changing the inhalation temperature and relative humidity were more pronounced as well.
At the same relative humidity and temperature of the inhaled air, the total volume of air surrounding each droplet is
increased when the inhalation ﬂow is increased. Therefore, much more water can evaporate before the air is saturated,
resulting in smaller droplets near the center of the airway. The effect is smaller near the airway wall, where it takes a bit
longer for the air to be saturated and cause slightly slower condensation before equilibrium is reached. If besides the
inhalation ﬂow also the temperature or the relative humidity is changed, the effect on droplet size distribution becomes
more pronounced as the change in moisture capacity due to both parameters also depends on the volume of air. The same
change in temperature from 293 K to 303 K or a change in relative humidity from 35% to 70% will result in a much bigger
change in moisture capacity at a high inhalation ﬂow rate than at a lower inhalation ﬂow rate.
When the relative humidity in the respiratory tract is limited to a maximum of 104%, there is an overall decrease in the
droplet size distribution compared to the scenario where the relative humidity in the respiratory tract is unlimited.
Although droplets in the center of the airway only reduce less than 0.5 mm in size, due to the larger decrease in droplet size
near the airway wall, there is a noticeable reduction in the width of the droplet size distribution. Furthermore, there is a
decrease of the volume fraction of droplets with a size larger than the originally inhaled droplets of 4.5 mm.
Finally, when the relative humidity was limited to 100%, no growth of droplets is observed. Instead, the droplet diameter
does not change when close to the airway wall and decreases when closer to the center of the airway. Compared to the
scenario where the relative humidity is limited to 104%, the width of the droplet size distribution remains the same,
although the distribution shifts towards smaller droplets with no fraction larger than the original droplet size.4. Discussion
It is shown that the developed droplet model can be used to accurately estimate the shrinkage or growth of a droplet by
evaporation or condensation, respectively. When this droplet model is coupled to the Weibel model of the lung to obtain the
respiratory tract model, estimations can be made regarding the behavior of inhaled droplets in the respiratory tract. Our
simulations indicate that whether a droplet grows or shrinks is dependent on where the droplet is situated with regard to
the airway wall (Figs. 3–5). When close to the wall, the relatively cold droplet is quickly subjected to an environment of
higher temperature and humidity which promotes condensational growth, resulting in larger droplets. However, droplets
farther away from the wall will ﬁrst evaporate before the heat and moisture from the airway wall will reach these droplets.
These changes in droplet size distribution happen rather quickly, as it was found that at generation 9–10 the conditions
inside the airway will have reached equilibrium and no further change in droplet size occurs. Therefore, there could be a
substantial effect of this change in droplet size distribution on the deposition site. Instead of reaching the lower airways, the
larger droplets (which are, as shown in the results, already closer to the airway wall) will be deposited higher in the
respiratory tract than might be originally intended, thereby reducing the efﬁcacy of the inhalation therapy, while the
smaller droplets will deposit deeper in the respiratory tract than originally intended. Knowing the behavior of the droplets
inside the respiratory tract can help in countering the effect with either changes in formulation, design of the inhalation
device, or inhalation instructions.
Although the idea of droplet growth and shrinkage in the respiratory tract is not new, we have developed a basic model
that enables one to estimate the effect of various conditions on inhaled droplets. The model demonstrates the relevance of
temperature and relative humidity of the inhaled air and inhalation ﬂow rate to the behavior of inhaled droplets in the
respiratory tract. Furthermore, the model is made available freely for anyone to use and adapt. Due to the step by step
approach using discrete equations, we hope to enable users to easily understand and expand the model to further improve
the accuracy and perhaps complexity. While a more accurate and complete result might be obtained with a full compu-
tational ﬂuid dynamics (CFD) model, the simplicity of this model is easier to understand and adapt by researchers that are
not involved in the ﬁeld of CFD.
The conditions at which the aerosol is inhaled determine the magnitude of the effects on changes in size distribution.
Both the relative humidity and the temperature of the inhaled air were found to have a noticeable effect on the fraction of
droplets smaller than the inhaled droplets, and thus on the deposition in the respiratory tract. With increasing relative
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deposition will shift toward lower regions of the respiratory tract. Although the conditions during inhalation will change
inevitably with location and season, it is something to keep in mind when developing devices for worldwide applications. It
could, for example, be worthwhile to look into air conditioning methods that are built into the device to reduce the effects
when the deposition site is critical.
Also the rate at which the aerosol is inhaled is of importance. Especially in the case of the Respimat
s
soft mist inhaler,
which ejects the aerosol in a ﬁxed timeframe, the concentration of the droplets in the air mainly inﬂuences the evaporation
of droplets in the center of the airway. With more diluted droplets (fast inhalation), it takes longer for the air in the center of
the airway to saturate, allowing droplets to evaporate more. This in turn results in a smaller droplet size than when the
aerosol is slowly inhaled. Therefore, depending on the device, the instructions should clearly specify which type of inha-
lation is required. Furthermore, the resistance of the inhaler can also play an important role here. A high resistance inhaler
will promote slow inhalation, whereas a low resistance inhaler will allow for a fast inhalation, but not necessarily enforce
one. Finally, whether or not the inhalation is performed fast or slow will also affect the ﬂow regime inside the respiratory
tract. When the air is inhaled slowly, the ﬂow regime will be closer to laminar, also in the upper airways. However, when the
air is inhaled faster, the ﬂow will be more turbulent, by which the behavior of the droplets inside the respiratory tract will
change. Also worth mentioning is that the same result of a change in inhalation ﬂow rate can be obtained by an equal
inverse change of the inhaled amount of droplets of the same size, because the concentration of droplets in the inhaled air
will in that case be the same.
Because the concentration of the generated droplets in the inhaled air can affect the behavior of the droplets in the
respiratory tract, the aerosol ejection proﬁle from the inhaler and the inhalation ﬂow proﬁle can also play a role. To
minimize variations due to growth and shrinkage of droplets during inhalation, a constant inhalation ﬂow and a square
ejection proﬁle, where the maximum throughput is reached instantly and also ends instantly, is preferred. However, in
reality there will be a gradual increase and decrease in the ejected volume from the device, the droplets at the beginning
and at the end of the ejection will be diluted more than droplets ejected in the middle, when the ejected ﬂow is higher. In
part, this could be counteracted by the inhalation ﬂow proﬁle, which will also not be square. At the start of the inhalation
procedure the inhalation ﬂow will increase until a maximum is reached and then slowly decrease again. This will also affect
the behavior of inhaled droplets in the respiratory tract differently, similar to the inhalation ﬂow rate. These notices could
also be taken into account when designing a new generation of Adaptive Aerosol Delivery systems (Dhand, 2010), with an
even further improved control over lung deposition.
It has to be noted that there are several limitations to the model that should be kept in mind. First of all, the model
proposed in this study assumes a fully laminar ﬂow. While this is true for the largest part, the ﬂow in the ﬁrst few (two to
four) generations may be turbulent (Olson, Sudlow, Horsﬁeld & Filley, 1973). This will have an effect on the behavior of the
droplets in the respiratory tract. It can be expected that under turbulent conditions, the difference between the center of the
airway and the layers close to the airway wall is smaller. Both the temperature and the relative humidity gradients will be
smaller and there will be some mixing of the droplets throughout the airway. This should result in a smaller droplet size
distribution, as droplets near the airway wall will grow less and droplets near the center of the airway will evaporate less. In
fact, in an ideally mixed system, the droplets would all have the same size. This system is the opposite extreme compared to
our fully laminar system. However, when the ﬂow becomes laminar after 2–4 generations, the droplet size distribution will
most likely become wider again due to the formation of a temperature and relative humidity gradient. It is possible that, due
to increased mass and heat transfer under turbulent conditions from the airway wall to the airway, the average droplet size
will increase when turbulent conditions are considered in the ﬁrst few generations. Therefore, it may be worthwhile to
expand the model in the future to also include the various ﬂow regimes that are encountered in the subsequent generations
of the respiratory tract.
Furthermore, the heat and moisture transferred to the inhaled air during passage from the mouth to the trachea that was
omitted could change the location in the respiratory tract where equilibrium is reached. If fully laminar ﬂow were to be
assumed for this region as well then the resulting changes in droplet size would most likely change very little, because the
conditions would be similar as in the trachea. More speciﬁcally, the droplets near the center will shrink to the same size,
because the air will be saturated as this also happens in the trachea (Figs. 3 and 4) and only droplets near the wall might
have a bit more time to grow. However, equilibrium will be reached sooner, perhaps after only a few generations depending
on the inhalation ﬂow. However, it is known that the ﬂow in this region is slightly turbulent and more accurate results
would be obtained by taking this into account when expanding the model (Olson et al., 1973).
Another aspect that is not considered in the model, but might be very important under laminar ﬂow conditions, is the
inﬂuence of the bifurcations. In our model, the airway simply reduces in size (following the Weibel model) but retains the
internal distribution of the droplets. However, under fully laminar conditions, the airway is split in half and the droplets at
the center of the airway are suddenly close to the airway wall and exposed to conditions that enhance condensational
growth. Therefore, the droplets that are originally located in the center will have less time to evaporate before they start to
grow after the bifurcation. This could cause an overall increase in the droplet size due to limited evaporation of droplets in
the center compared to what is simulated in our model. However, it was also shown that the evaporation of the droplets
near the center of the airway reaches equilibrium due to saturation of the air with moisture (Figs. 3 and 4). This equilibrium
is under most conditions reached before the end of generation zero, the trachea, thus before any bifurcations are
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overall droplet size distribution will be small.
Furthermore, the hygroscopicity of solutes is not included in the model. A lot is known about the inﬂuence of solutes on
the growth on both particles and droplets, and it is possible to model these inﬂuences (Ferron, 1977; Golshahi et al., 2013;
Hindle & Longest, 2010; Longest & Hindle, 2010, 2011, 2012; Longest, McLeskey & Hindle, 2010; Longest, Tian & Hindle, 2011;
Longest et al., 2012; Tian et al., 2013, 2011; Worth Longest et al., 2012). The model without hygroscopicity can be used for
conditions where droplet growth is mainly caused by condensation instead of hygroscopicity, i.e. during inhalation of
aerosols where the relative humidity tends to reach over 100%. However, for inhalation of solid particles or aerosols with
solutes at lower relative humidity there will be an underestimation of droplet growth due to the sizeable contribution of
hygroscopicity to particle growth. Because of the stepwise calculation using discrete equations, the addition of such
inﬂuence should be quite straightforward and is intended to be done during future development. Therefore, although
current results will give a slight underestimation of the droplet size due to the absence of solute hygroscopicity (Fig. 2),
future expansions of the model can improve the accuracy. In addition to more accurate results for aerosols, this will also
make the model more suitable for particle behavior in the respiratory tract. However, current results indicate that the same
effects can be expected for dry particles, since both relative humidity and temperature will dictate how much water will be
taken up by dry particles. Therefore, it can be assumed that particles near the airway wall will grow more than particles in
the center of the airway when the airﬂow is laminar.
Finally, it is unknown exactly how much the exclusion of nucleation at an RH4100% will inﬂuence the behavior of
inhaled droplets inside the respiratory tract. It is clearly shown that the reduction of the maximum relative humidity due to
possible nucleation will deﬁnitely affect the droplet growth near the airway wall, as can be expected. However, it is
unknown how much water will nucleate and form separate droplets that do not coalesce with the inhaled droplets. An
experimental setup, as was used by Longest et al. and Hindle et al. (Hindle & Longest, 2012; Longest & Hindle, 2010, 2012;
Longest et al., 2010), could help to tune the model to more exact results. Despite the fact that the actual size distribution of
the droplets can shift depending on the effect of nucleation at high relative humidity, the practical implications of the results
remain unchanged.5. Conclusion
The developed model was used to predict the inﬂuence of several parameters on the behavior of inhaled aqueous
droplets in the respiratory tract. It was found that, under laminar conditions, the location of the droplet with respect to the
airway wall determines whether a droplet will grow or shrink. Droplets in the center of the airway will ﬁrst evaporate until
the air is saturated, while droplets near the airway wall will immediately start to grow due to condensation. The extent of
the effects is also shown to be largely inﬂuenced by the relative humidity and temperature of the inhaled air, and the
inhalation ﬂow rate. Understanding how these factors inﬂuence the behavior of inhaled droplets can help during for-
mulation, design of the inhalation device, or inhalation instructions. Furthermore, the model can easily be adapted to
include phenomena such as turbulent ﬂow, hygroscopic growth, and others that can help to improve the accuracy of the
model. In addition, these additions could also make the model applicable to dry powders.Acknowledgments
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